Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial

PURPOSE: Infected pancreatic necrosis (IPN) is a highly morbid complication of acute necrotising pancreatitis (ANP). Since there is evidence of early-onset immunosuppression in acute pancreatitis, immune enhancement may be a therapeutic option. This trial aimed to evaluate whether early immune-enhan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Lu, Zhou, Jing, Mao, Wenjian, Chen, Tao, Zhu, Yin, Pan, Xinting, Mei, Hong, Singh, Vikesh, Buxbaum, James, Doig, Gordon, He, Chengjian, Gu, Weili, Lu, Weihua, Tu, Shumin, Ni, Haibin, Zhang, Guoxiu, Zhao, Xiangyang, Sun, Junli, Chen, Weiwei, Song, Jingchun, Shao, Min, Tu, Jianfeng, Xia, Liang, He, Wenhua, Zhu, Qingyun, Li, Kang, Yao, Hongyi, Wu, Jingyi, Fu, Long, Jiang, Wendi, Zhang, He, Lin, Jiajia, Li, Baiqiang, Tong, Zhihui, Windsor, John, Liu, Yuxiu, Li, Weiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205279/
https://www.ncbi.nlm.nih.gov/pubmed/35713670
http://dx.doi.org/10.1007/s00134-022-06745-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205279/
https://www.ncbi.nlm.nih.gov/pubmed/35713670
http://dx.doi.org/10.1007/s00134-022-06745-7

Ejemplares similares